title: Mechanisms of perturbation of erythrocyte calcium homeostasis in favism.
abstract: Favism is an acute hemolytic anemia triggered by ingestion of fava beans in genetically susceptible subjects with severe deficiency of glucose-6-phosphate dehydrogenase (G6PD) activity. Erythrocytes from 10 favic patients had constantly and markedly increased calcium levels, as compared with values detected in 4 asymptomatic G6PD-deficient controls. Correspondingly, the calcium permeability of erythrocytes, estimated as the fraction of intracellular calcium exchangeable with externally added 45Ca2+, was invariably enhanced in favism and returned to normal patterns after several months from the acute hemolytic crisis. In favic patients, the levels of erythrocyte calcium ATPase activities showed wide variability, ranging from 2.0-12.9 mumol Pi/ml RBC/h, while control values in asymptomatic G6PD-deficient subjects were 10.62 +/- 2.03 mumol Pi/ml RBC/h. Analysis of the calcium ATPase in situ in erythrocyte membranes from favic patients showed the same molecular mass of 134 kD as observed in the control subjects. Exposure of G6PD-deficient erythrocytes in vitro to autoxidizing divicine, a pyrimidine aglycone strongly implicated in the pathogenesis of favism which leads to late accumulation of intracellular calcium, caused: (i) a marked inactivation of calcium ATPase, without changes in the molecular mass of 134 kD; and (ii) the concomitant loss of spectrin, band 3 and band 4.1, all known substrates of the calcium activated procalpain-calpain proteolytic system. Thus, the increased intraerythrocytic calcium apparently results in the degradation of calcium ATPase observed in some favic patients. It is proposed that both enhanced calcium permeability and a calcium-stimulated degradation of the calcium pump are the mechanisms responsible for the perturbation of erythrocyte calcium homeostasis in favism.
authors.affiliation: Institute of Biochemistry, University of Genoa, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Damonte
authors.forename: L
authors.initials: L
authors.lastname: Guida
authors.forename: A
authors.initials: A
authors.lastname: Sdraffa
authors.forename: U
authors.initials: U
authors.lastname: Benatti
authors.forename: E
authors.initials: E
authors.lastname: Melloni
authors.forename: G
authors.initials: G
authors.lastname: Forteleoni
authors.forename: T
authors.initials: T
authors.lastname: Meloni
authors.forename: E
authors.initials: E
authors.lastname: Carafoli
authors.forename: A
authors.initials: A
authors.lastname: De Flora
mesh_terms: D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000097:blood*; D000252:Calcium-Transporting ATPases / Q000097:blood* / Q000187:drug effects; D002154:Calpain / Q000494:pharmacology; D004912:Erythrocytes / Q000378:metabolism*; D005236:Favism / Q000097:blood*; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D006706:Homeostasis; D006801:Humans; D008297:Male; D010084:Oxidation-Reduction; D011744:Pyrimidinones / Q000494:pharmacology
chemical_list: D011744:Pyrimidinones; C026511:divicine; D000001:Calcimycin; D005954:Glucosephosphate Dehydrogenase; D002154:Calpain; D000252:Calcium-Transporting ATPases; D002118:Calcium